Skip to content

KLRS KLRS Shares (Basic)

Shares (Basic) at other companies

Eli Lilly logo
Eli LillyLLY
894.5M-0.5%
Amgen logo
AmgenAMGN
540M+0.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
104M-2.5%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
86M+23.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
224.1M+32.3%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
61.9M+17.3%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's shares (basic)?
KLRS (KLRS) reported shares (basic) of 23.7M in Q1 2026.
How has KLRS's shares (basic) changed year-over-year?
KLRS's shares (basic) increased by 485.3% year-over-year, from 4.1M to 23.7M.
What is the long-term trend for KLRS's shares (basic)?
Over 2 years (2023 to 2025), KLRS's shares (basic) has grown at a -57.0% compound annual growth rate (CAGR), from 306.3M to 56.7M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.